Objective: To clear the role of peripheral blood as a substitution for bone marrow in myelodysplastic syndrome and to evaluate the concordance between peripheral blood and bone marrow using karyotype and fluorescence in situ hybridization (FISH) methods.
| INTRODUC TI ON
Myelodysplastic syndrome (MDS) is heterogeneous clonal disorder of hematopoiesis, resulting from acquired genetic lesions in bone marrow (BM) stem cells. MDS disorder is characterized by ineffective hematopoiesis leading to peripheral blood (PB) cytopenias and malignancy. [1] [2] [3] [4] Chromosomal investigation of bone marrow is essential for MDS diagnosis and also provides information for determining classification, prognosis, and even treatment of disease. The most common method for cytogenetic abnormality assessment in MDS is karyotype; although in about 50% of the cases, karyotype results are uninformative. 2, 5, 6 In addition, fluorescence in situ hybridization (FISH)
is a relatively common diagnostic testing and, in comparison with karyotype, it can detect more detailed abnormalities without any cultivation, although there is not enough evidence for the best setting of the useful probe selection. 3, 7, 8 The cytogenetic examination of bone marrow specimen is an essential step in MDS diagnosis, but bone marrow aspiration is a very painful procedure, especially in hypocellular (10-16%) or fibrotic cases (17%) and also frequent sampling for disease monitoring is a clinical challenge. 3, 5, 9, 10 The cytogenetic analysis of peripheral blood for diagnosis and disease management provides a less-invasive method instead of bone marrow aspiration, but the utility of peripheral blood to use in FISH and specially karyotype is not clear and additional studies can provide further information to compare the cytogenetic of BM and PB. 1 Several studies compared the results of FISH and karyotype methods using BM samples, but in this study, we compared the results of karyotype and FISH in each of the BM and PB specimens. 8, [11] [12] [13] [14] [15] [16] [17] As karyotype is the most popular method for cytogenetic abnormality assessment, the survey in this field can be useful. 5, 18 In this study, we applied optimized karyotype for PB samples. We used MDS-related probes in FISH method for determining the most common MDS cytogenetic abnormalities −5/5q−, −7, +8 and 20q− in both BM and PB specimens.
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2 | PATIENTS AND ME THODS
| Case selection
All bone marrow samples submitted to the Genome medical ge- 
| Karyotype
Metaphase cytogenetic was performed using PB and BM samples in Genome medical genetic laboratory of Isfahan. It should be noted that both PB and BM sampling were collected concurrently.
Metaphase cytogenetic stepwise procedure relies on cell cultivating, followed by chromosomal harvesting, metaphase spread preparation, and chromosomal banding. Karyotype method for BM and PB samples performed using standard protocol with an exception for peripheral blood in which growth factor for cultivation was not used. Because of not using growth factor, we had to set up the time of cultivation that we gained the most number of metaphases. Similar to the karyotype, FISH was performed using BM and PB samples in Genome medical genetic laboratory of Isfahan. We prepared microscopic slides for FISH method from each of the BM and PB samples directly and with no culturing. After slide preparation, 2× SSC solution treatment was performed, and then, slides were exposed to pepsin, followed by the application of probes. The slides were later placed in hybridizer for hybridization. For each sample, at least 200 cells were examined for each of the probes by 2 different individuals.
| RE SULTS
We performed karyotype and FISH methods on 35 BM and PB specimens obtained from MDS suspected patients. Three microscope slides were used for FISH study of each sample: one slide for both chromosomes 7 and 8, one slide for chromosome 20, and one for chromosome 5 ( Table 2) . 
TA B L E 1 Summary of the patient's demography data

Type of information
Number of patients
| Karyotype: BM vs PB
According to our data, 14 of 35 cases were shown to be normal by both sample types. Twelve of the rest of 21 cases showed the same chromosome abnormality by both methods. Peripheral blood karyotype failed for 9 cases, while in 3 of the 9 failed cases, bone marrow karyotype also failed (Table 3) . 
| FISH: BM vs PB
| PB: karyotype vs FISH
The FISH method using PB samples was more useful in comparison with BM samples for detecting the mutations in cases with normal or failed karyotype. FISH method detected the abnormalities in 4
cases, while all of this 4 cases had failed peripheral blood karyotype.
However, in 8 of 35 peripheral blood cases, karyotype could provide additional information in cases with normal FISH results ( Table 5 ).
| D ISCUSS I ON
This study attempted to investigate the utility of peripheral blood in comparison with bone marrow for cytogenetic abnormality detection. In addition to compare the results of karyotype and FISH in each of the PB and BM samples, and finally to evaluate the diagnostic efficacy of −5/5q, −7, +8 and −20q MDS-associated probe.
Generally, BM karyotype is considered as the most common cytogenetic method for myeloid neoplasm genetic assessment.
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But in some cases with noninformative BM karyotype such as inappropriate metaphase spread or cryptic abnormality, FISH clarifies additional information. 1 There have been several studies regarding the usefulness of MDS-associated FISH panel in BM samples. These studies determined the most useful probes in MDS; however, the majority of these studies reported the superiority of FISH method in about 10%-20% of cases. 4, 7, [11] [12] [13] [14] [15] [16] [17] [18] In this study, the most common MDS-associated FISH panel probe was used and the results showed FISH superiority in fewer than 10% of cases. It should be noted that according to our data, some changes in this set of probes are useful to increase the rate of abnormality detection. According to recent studies, centromeric probes for chromosomes 7 and 8 are the members of most useful probe set, to detect numerical abnormality in chromosomes 7 and 8; whereas using probes that are specified to a defined region in one arms of the chromosome not only can show numerical abnormality but also can investigate mutation in determined region. For example, in the patients 23 and 26, the FISH method could not detect the mutation in the long arm of chromosome 7. However, the FISH method cannot determine the mutations out of the regions which have targeted by probes; for example, deletion in the case 5 was detected just by karyotype method, and the FISH result was normal.
According to the results, in comparison with karyotype, FISH provides additional information in 3 of the totally 18 abnormal (in other words, in 16% of the abnormal cases and 8% of all cases). It should be noted that from these 3 cases, just one case had adequate BM cytogenetic metaphase. In conclusion, the study showed that successful karyotype itself is the most useful cytogenetic method for MDS diagnosis.
In the second part of the study, the concordance between BM and PB samples was measured. As already mentioned, the concordance between BM and PB sample using FISH method was appropriate, but the rate of abnormality detection using FISH method is not appropriate in both types of samples. As a result, examining peripheral blood using FISH method seems to be useful in the patient with known abnormality, and this usually occurs in disease monitoring and it could be useful to avoid serial bone marrow aspiration. 18 In summary, however, karyotype of peripheral blood is not trustworthy for MDS diagnosis, but examining peripheral blood, using FISH, could be useful to avoid serial bone marrow sampling for clinical monitoring and also this would be worthful in the treatment.
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